In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the recent court judgment on the U.S. Food and Drug Administration’s (FDA) oversight of lab-developed tests (LDT). They covered: 
 

• Details about the ruling to vacate the FDA’s rule on LDT oversight. 
• What LDT oversight might look like in the future. 
• How the laboratory medicine industry can help create an oversight approach that is positive for both patients and innovation.